2seventy bio, Inc. (NASDAQ:TSVT) Receives Consensus Rating of “Moderate Buy” from Analysts
2seventy bio, Inc. (NASDAQ:TSVT – Get Free Report) has been given an average rating of “Moderate Buy” by the nine research firms that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, four have given a buy rating and one […]
More Stories
FT Vest SMID Rising Dividend Ac (NYSEARCA:SDVD) Announces Dividend of $0.14
FT Vest SMID Rising Dividend Ac (NYSEARCA:SDVD – Get Free Report) announced a dividend on Friday, November 22nd,NASDAQ Dividends reports....
Airports of Thailand Public Company Limited (OTCMKTS:AIPUY) Plans Dividend Increase – $0.16 Per Share
Airports of Thailand Public Company Limited (OTCMKTS:AIPUY – Get Free Report) announced a dividend on Saturday, November 23rd,NASDAQ Dividends reports....
Corning Natural Gas (OTCMKTS:CNIG) vs. Centuri (NYSE:CTRI) Financial Comparison
Centuri (NYSE:CTRI – Get Free Report) and Corning Natural Gas (OTCMKTS:CNIG – Get Free Report) are both utilities companies, but...
Critical Analysis: Lucas GC (NASDAQ:LGCL) versus Sangoma Technologies (NASDAQ:SANG)
Institutional & Insider Ownership 39.7% of Sangoma Technologies shares are owned by institutional investors. 14.0% of Sangoma Technologies shares are...
Americans Need $5.3 Million Net Worth to Be Considered Financially Successful: Survey
By Naveen Athrappully Americans have high expectations of what it means to be financially successful but many of them do...
2 Key Congressional Races Still Uncalled in California
By Kimberly Hayek Republicans have secured a trifecta in the November general election, taking control of the Oval Office, House,...